Thrivent Financial for Lutherans’s Regenxbio RGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-12,205
Closed -$176K 2649
2025
Q4
$176K Sell
12,205
-22,798
-65% -$284K ﹤0.01% 2538
2025
Q3
$338K Buy
+35,003
New +$310K ﹤0.01% 2200
2024
Q4
Sell
-35,706
Closed -$375K 2593
2024
Q3
$375K Sell
35,706
-1,913
-5% -$23.3K ﹤0.01% 2330
2024
Q2
$440K Buy
37,619
+2,508
+7% +$39K ﹤0.01% 2271
2024
Q1
$740K Sell
35,111
-953
-3% -$17K ﹤0.01% 2061
2023
Q4
$647K Sell
36,064
-933
-3% -$16.4K ﹤0.01% 2110
2023
Q3
$609K Buy
36,997
+822
+2% +$14.9K ﹤0.01% 2041
2023
Q2
$723K Sell
36,175
-1,152
-3% -$22.2K ﹤0.01% 2007
2023
Q1
$706K Sell
37,327
-1,309
-3% -$29K ﹤0.01% 1977
2022
Q4
$876K Sell
38,636
-21,408
-36% -$484K ﹤0.01% 1812
2022
Q3
$1.59M Buy
60,044
+22,751
+61% +$675K ﹤0.01% 1377
2022
Q2
$921K Buy
37,293
+6,654
+22% +$166K ﹤0.01% 1758
2022
Q1
$1.02M Buy
30,639
+10
+0% +$278 ﹤0.01% 1821
2021
Q4
$1M Buy
30,629
+326
+1% +$11.1K ﹤0.01% 1855
2021
Q3
$1.27M Buy
30,303
+1,807
+6% +$65K ﹤0.01% 1676
2021
Q2
$1.11M Sell
28,496
-131
-0.5% -$4.68K ﹤0.01% 1771
2021
Q1
$976K Buy
28,627
+3,862
+16% +$165K ﹤0.01% 1886
2020
Q4
$1.12M Hold
24,765
﹤0.01% 1673
2020
Q3
$682K Sell
24,765
-1,731
-7% -$56.4K ﹤0.01% 1809
2020
Q2
$976K Buy
26,496
+228
+0.9% +$8.5K ﹤0.01% 1510
2020
Q1
$851K Buy
26,268
+1,311
+5% +$54.6K ﹤0.01% 1400
2019
Q4
$1.02M Buy
24,957
+99
+0.4% +$3.91K ﹤0.01% 1465
2019
Q3
$885K Buy
24,858
+858
+4% +$34.8K ﹤0.01% 1493
2019
Q2
$1.23M Buy
24,000
+1,004
+4% +$50.1K ﹤0.01% 1268
2019
Q1
$1.32M Buy
22,996
+1,816
+9% +$90K ﹤0.01% 1185
2018
Q4
$888K Buy
21,180
+742
+4% +$43.5K ﹤0.01% 1231
2018
Q3
$1.54M Buy
20,438
+2,035
+11% +$147K ﹤0.01% 1016
2018
Q2
$1.32M Buy
+18,403
New +$879K ﹤0.01% 1086

Other funds holding RGNX